Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000299247 is annotated as a novel RNA transcript on the antisense strand of the protein-coding gene CDS2. No protein product is currently annotated and no regulatory, pathological, or molecular function is described in curated databases[1]. Such antisense transcripts are sometimes involved in the regulation of their corresponding sense gene, but there is no evidence for a characterized function for this particular transcript. This entry is not considered a classical therapeutic target such as a receptor, enzyme, transporter, or disease marker, and may represent a transcript discovered computationally that is yet unvalidated or functionally undefined in the literature[1][4][7].\n\nKey points:\n- This entry does not refer to a protein, receptor, enzyme, or druggable target.\n- There is no clinical or preclinical evidence for its use as a therapeutic biomarker, nor any interacting drugs or safety considerations.\n- Its annotation as \"novel transcript, antisense to CDS2\" indicates uncharacterized function, limited biological understanding, and a non-target status.\n- Antisense RNAs can regulate gene expression epigenetically or by RNA interference, but there is no evidence this transcript has such a function in the current literature[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to CDS2 (ENSG00000299247).